November 24, 2021
On the 23rd of November, APPRISE co-hosted a forum with the BEAT COVID collaboration. The forum addressed outstanding community questions about COVID-19 vaccines.
Our three panellists – Professor Tania Sorrell, Professor Sharon Lewin and Associate Professor Nick Wood – addressed a variety of excellent questions, moderated by Dr Miranda Smith. The panel addressed questions including:
- issues around the timing of booster vaccines,
- the impact of vaccines on people with immunosuppression,
- what we need to consider around vaccinating children under 12 years of age, and
- details of the post-vaccine surveillance systems that track and help to identify adverse reactions.
Watch the video of the session here:
Additional resources referenced in the discussion include:
- ATAGI advice on 3rd dose for immunocompromised people: https://www.health.gov.au/resources/publications/atagi-recommendations-on-the-use-of-a-third-primary-dose-of-covid-19-vaccine-in-individuals-who-are-severely-immunocompromised
- Paper on vaccine response in people receiving cancer therapy: Webber T, Provinciali N, Musso M, et al. Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment. 2021. Available from: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3901796.
- Vaccine safety monitoring: https://ausvaxsafety.org.au/
- Paper on considerations for vaccinating children under 12 years of age: , , , et al. Should children be vaccinated against COVID-19. 2021. Available from: https://adc.bmj.com/content/early/2021/11/01/archdischild-2021-32304
- Explainer on mRNA vaccines: https://theconversation.com/messenger-rna-how-it-works-in-nature-and-in-making-vaccines-166975